<SEC-DOCUMENT>0000939767-23-000003.txt : 20230109
<SEC-HEADER>0000939767-23-000003.hdr.sgml : 20230109
<ACCEPTANCE-DATETIME>20230109161504
ACCESSION NUMBER:		0000939767-23-000003
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230108
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230109
DATE AS OF CHANGE:		20230109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXELIXIS, INC.
		CENTRAL INDEX KEY:			0000939767
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				043257395
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30235
		FILM NUMBER:		23518243

	BUSINESS ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502
		BUSINESS PHONE:		6508377000

	MAIL ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS INC
		DATE OF NAME CHANGE:	20000207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20000106
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>exel-20230108.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:df7852c8-f4a3-4fc5-8660-dc137a23d35f,g:ba2d0e8a-471d-48f3-a51a-d61364ac11d5,d:592d7aa868574aeca0dfd0308c2d6241--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>exel-20230108</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV80L2ZyYWc6OTMxNTJhNTZlZGU2NGNhYzgxZjMxODI4MjRmODg0ZDAvdGFibGU6YWQ0NjUzMjdkZjcwNDRiYTk3ODY1MmJjMjU2ODlkZGMvdGFibGVyYW5nZTphZDQ2NTMyN2RmNzA0NGJhOTc4NjUyYmMyNTY4OWRkY18yLTEtMS0xLTEwMDE3MQ_031a00dc-fcfb-4c5f-8801-f66a8df1d44e">0000939767</ix:nonNumeric><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV80L2ZyYWc6OTMxNTJhNTZlZGU2NGNhYzgxZjMxODI4MjRmODg0ZDAvdGFibGU6YWQ0NjUzMjdkZjcwNDRiYTk3ODY1MmJjMjU2ODlkZGMvdGFibGVyYW5nZTphZDQ2NTMyN2RmNzA0NGJhOTc4NjUyYmMyNTY4OWRkY181LTEtMS0xLTEwMDE3MQ_82aeaf7e-19ef-4a29-ada6-45b8bc93455c">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="exel-20230108.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000939767</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-08</xbrli:startDate><xbrli:endDate>2023-01-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i592d7aa868574aeca0dfd0308c2d6241_1"></div><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:199.50pt"><tr><td style="width:1.0pt"></td><td style="width:97.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:97.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:2pt;text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:100%">FORM </span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6YjAyMjBlNjdjMWIxNDA5Y2E0MzAwNDllZjQ2MjhmZjEvdGFibGVyYW5nZTpiMDIyMGU2N2MxYjE0MDljYTQzMDA0OWVmNDYyOGZmMV8wLTEtMS0xLTEwMDE3MQ_674ad8b8-f357-4f4b-8e33-c3f217bed6c8">8-K</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN181NDk3NTU4MTU1NTQ_b89c4d99-3153-406d-bea1-aeaa660bfb84">January 8, 2023</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:200.25pt"><tr><td style="width:1.0pt"></td><td style="width:198.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:57pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="exel-20230108_g1.jpg" alt="exel-20230108_g1.jpg" style="height:64px;margin-bottom:5pt;vertical-align:text-bottom;width:190px"/></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6MzBhMzA1YTQwOTkwNGU5OTk5MzYyYTI0Yzk2OTA0ZWEvdGFibGVyYW5nZTozMGEzMDVhNDA5OTA0ZTk5OTkzNjJhMjRjOTY5MDRlYV8xLTAtMS0xLTEwMDE3MQ_c3e1d3d4-766a-41b2-be16-c63a3bb9dd32">EXELIXIS, INC.</ix:nonNumeric></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6ZjBkYjRkNzYxM2I2NGUxYmE0OWQ5MGUyYzcxMTJhODAvdGFibGVyYW5nZTpmMGRiNGQ3NjEzYjY0ZTFiYTQ5ZDkwZTJjNzExMmE4MF8wLTAtMS0xLTEwMDE3MQ_e86290bf-d76e-4adb-9323-8c7f4b4f1514">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6ZjBkYjRkNzYxM2I2NGUxYmE0OWQ5MGUyYzcxMTJhODAvdGFibGVyYW5nZTpmMGRiNGQ3NjEzYjY0ZTFiYTQ5ZDkwZTJjNzExMmE4MF8wLTEtMS0xLTEwMDE3MQ_6ea926ae-4414-44c2-8a25-67bd9bc3035d">000-30235</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6ZjBkYjRkNzYxM2I2NGUxYmE0OWQ5MGUyYzcxMTJhODAvdGFibGVyYW5nZTpmMGRiNGQ3NjEzYjY0ZTFiYTQ5ZDkwZTJjNzExMmE4MF8wLTItMS0xLTEwMDE3MQ_754be6af-cf07-4266-9217-72d244f78b9a">04-3257395</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjAz_a7f9835c-85e0-4f5f-96ed-8e1664b0cc7d">1851 Harbor Bay Parkway</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjA0_61c4e396-47ce-4722-84c2-f9e2062100d4">Alameda</ix:nonNumeric>, <ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjA5_da81524f-a834-4ef7-bef5-0816aa05c2ce">California</ix:nonNumeric> <ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNTk4_20030266-d5aa-4bec-804f-be4c485f47ad">94502</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjA1_68357d44-61d4-4e72-9d1d-49cb270229bb">650</ix:nonNumeric>) <ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNTk5_10852b01-cd6a-4e61-8946-2c6e2aec3280">837-7000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:9pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjA2_b790cbf2-07e6-4469-9c55-b3df18b73b80">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-top:9pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjAw_60a0dea0-48b4-4345-beaa-d9956e93a62f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-top:9pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjAx_24bd9b01-9663-4d4f-9a15-e8ced531acaf">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-top:9pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjAy_5816e705-988c-4274-b263-2dcfedcb7561">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.577%"><tr><td style="width:1.0%"></td><td style="width:38.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6YmE4NjIxOTZhZDc0NDgzYWExNDJjMjk1MzM1MjQwOGEvdGFibGVyYW5nZTpiYTg2MjE5NmFkNzQ0ODNhYTE0MmMyOTUzMzUyNDA4YV8xLTAtMS0xLTEwMDE3MQ_426a4d0a-cb79-475f-ad62-1e5738fbc6ec">Common Stock $.001 Par Value per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6YmE4NjIxOTZhZDc0NDgzYWExNDJjMjk1MzM1MjQwOGEvdGFibGVyYW5nZTpiYTg2MjE5NmFkNzQ0ODNhYTE0MmMyOTUzMzUyNDA4YV8xLTEtMS0xLTEwMDE3MQ_e0899279-50bd-4abe-a7d0-c13b38918f13">EXEL</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6YmE4NjIxOTZhZDc0NDgzYWExNDJjMjk1MzM1MjQwOGEvdGFibGVyYW5nZTpiYTg2MjE5NmFkNzQ0ODNhYTE0MmMyOTUzMzUyNDA4YV8xLTItMS0xLTEwMDE3MQ_5db133b0-f360-43ac-a638-62536e3bceb0">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjA3_8dd8bfd8-829b-480a-aa1e-3c6e8dc362bc">&#9744;</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i592d7aa868574aeca0dfd0308c2d6241_7"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02 Results of Operations and Financial Condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 8, 2023, Exelixis, Inc. (&#8220;Exelixis&#8221;) issued a press release announcing its preliminary unaudited financial results for the quarter and full year ended December 30, 2022, providing financial guidance for the full year ending December 29, 2023, and delivered an update on its business. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The preliminary unaudited financial results contained in the press release do not present all information for an understanding of Exelixis&#8217; financial condition as of December 30, 2022 and its results of operations for the quarter and year ended December 30, 2022. The audit of Exelixis&#8217; financial statements for the year ended December 30, 2022 is ongoing and could result in changes to the information in the press release. The press release also announced that Exelixis will report its complete audited financial results for the quarter and full year ended December 30, 2022 on February 7, 2023.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this report, including the exhibit hereto, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this report and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Exelixis, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) &#160;&#160;&#160;&#160;Exhibits.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a230108corporatepriorities.htm">Press Release Dated January 08, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i592d7aa868574aeca0dfd0308c2d6241_10"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.428%"><tr><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXELIXIS, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 9, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ J</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EFFREY</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. H</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSEKIEL</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jeffrey J. Hessekiel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, General Counsel and Secretary</span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a230108corporatepriorities.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0749be27feef48b79ac240b4581bb6b3_62"></div><div style="min-height:60.48pt;width:100%"><div><font><br></font></div></div><div style="padding-left:9pt;padding-right:9pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:138px"></div><div style="padding-left:9pt;padding-right:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.122%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:52.85pt;text-indent:-52.85pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investor Contacts&#58;</font></div><div style="padding-left:52.85pt;text-indent:-52.85pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Susan Hubbard</font></div><div style="padding-left:52.85pt;text-indent:-52.85pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EVP, Public Affairs &#38; Investor Relations</font></div><div style="padding-left:52.85pt;text-indent:-52.85pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exelixis, Inc.</font></div><div style="padding-left:52.85pt;text-indent:-52.85pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">650-837-8194</font></div><div style="padding-left:52.85pt;text-indent:-52.85pt"><font style="color:#006ba6;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">shubbard&#64;exelixis.com</font></div><div style="padding-left:52.85pt;text-indent:-52.85pt"><font><br></font></div><div style="padding-left:52.85pt;text-indent:-52.85pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chris Senner</font></div><div style="padding-left:52.85pt;text-indent:-52.85pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chief Financial Officer</font></div><div style="padding-left:52.85pt;text-indent:-52.85pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exelixis, Inc.</font></div><div style="padding-left:52.85pt;text-indent:-52.85pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">650-837-7240</font></div><div style="padding-left:52.85pt;text-indent:-52.85pt"><font style="color:#006ba6;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">csenner&#64;exelixis.com</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Media Contact&#58; </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Hal Mackins</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">For Exelixis, Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">415-994-0040</font></div><div><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">hal&#64;torchcommunications.com</font></div><div><font><br></font></div><div><font><br></font></div></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exelixis Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results, <br>Provides 2023 Financial Guidance, and Outlines Key Priorities and Milestones for 2023</font></div><div style="padding-left:9pt;padding-right:9pt"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%">&#8211;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%"> Cabozantinib franchise achieves approximately $1.4 billion in preliminary U.S. net product revenues<br> for full year 2022, including approximately $375 million for fourth quarter 2022 </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%">&#8211;</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%">&#8211;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%"> Full year 2023 net product revenues guidance of $1,575 million - $1,675 million </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%">&#8211;</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%">&#8211;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%"> Corporate priorities for 2023 include readout of Phase 3 trials for cabozantinib, <br>expansion of the Phase 3 program for zanzalintinib, progression of XB002 into <br>full development, and advancement of Exelixis&#8217; earlier stage pipeline </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%">&#8211;</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%">&#8211;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%"> Presentation and webcast at 2023 J.P. Morgan Healthcare Conference on <br>Monday, January 9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.82pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.67pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%"> at 8&#58;15 p.m. ET &#47; 5&#58;15 p.m. PT </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-style:italic;font-weight:700;line-height:100%">&#8211;</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ALAMEDA, Calif. &#8211; January 8, 2023 &#8211;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Exelixis, Inc. (Nasdaq&#58; EXEL) today announced its preliminary unaudited financial results for the fourth quarter and full year 2022, provided financial guidance for full year 2023, and delivered an update on its business. Exelixis expects 2023 to be a year of significant growth and execution as it continues to expand and develop its pipeline of promising biotherapeutics and small molecules and pursues potential near-term label-expansion opportunities for CABOMETYX&#174; (cabozantinib).</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Preliminary Fourth Quarter and Full Year 2022 Financial Results &#38; 2023 Financial Guidance</font></div><div style="padding-left:9pt;padding-right:9pt"><font><br></font></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exelixis is providing the following preliminary unaudited 2022 financial results and financial guidance for 2023&#58; </font></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"></td><td style="width:22.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.737%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fourth Quarter 2022</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Full Year 2022</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Full Year 2023 Guidance</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#126; $415 million</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#126; $1,600 million</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,775 million - $1,875 million</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net product revenues</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#126; $375 million</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#126; $1,400 million</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,575 million - $1,675 million</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of goods sold</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126; 4.1%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126; 4.1%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.0% - 5.0%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126; $340 million</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126; $895 million</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million - $1,050 million</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126; $120 million</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126; $460 million</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$475 million - $525 million</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective tax rate</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n&#47;a</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n&#47;a</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20% - 22%</font></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Includes $10 million of non-cash stock-based compensation expense.</font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;Includes $45 million of non-cash stock-based compensation expense.</font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;Includes $45 million of non-cash stock-based compensation expense.</font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;Includes $15 million of non-cash stock-based compensation expense.</font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)&#160;&#160;&#160;&#160;Includes $62 million of non-cash stock-based compensation expense.</font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)&#160;&#160;&#160;&#160;Includes $55 million of non-cash stock-based compensation expense. </font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)&#160;&#160;&#160;&#160;Preliminary results not yet available.</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preliminary 2022 financial information presented in this press release has not been audited and is subject to change. The complete Exelixis Fourth Quarter and Full Year 2022 Financial Results are planned for release after market on Tuesday, February 7, 2023.</font></div><div style="height:20.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.48pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.888%"><tr><td style="width:1.0%"></td><td style="width:55.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">January 8, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page 2 of 6</font></div></td></tr></table><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;In 2023, Exelixis is advancing our diverse, high-impact pipeline of small molecule and biologic agents for oncology fueled by the continued growth of the cabozantinib commercial franchise,&#8221; said Michael M. Morrissey, Ph.D., President and Chief Executive Officer, Exelixis. &#8220;We expect to report data from two pivotal trials of cabozantinib, initiate the next wave of phase 3 studies of zanzalintinib (XL092), advance XB002 into full development and add new agents to our portfolio from internal discovery and collaborative efforts. Importantly, we&#8217;ll continue to pursue additional in-licensing and strategic opportunities to enhance the breadth and depth of our pipeline so that we can make an even greater impact on our mission to help cancer patients recover stronger and live longer.&#8221;</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Anticipated Pipeline Milestones</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exelixis made significant progress in establishing the potential of and adding new assets to the company&#8217;s pipeline in 2022. In 2022, Exelixis presented data sets for&#58; zanzalintinib (XL092), its next-generation oral tyrosine kinase inhibitor&#59; XB002, its most advanced antibody-drug conjugate (ADC)&#59; and XL102, a selective and irreversible cyclin-dependent kinase 7 (CDK7) inhibitor. Three promising biotherapeutics, XB010, XB014 and XB628, from internal discovery efforts are currently being evaluated in preclinical development, and collaborations were initiated with Cybrexa Therapeutics (Cybrexa) and Sairopa B.V. (Sairopa) to advance the CBX-12 and ADU-1805 programs, respectively, which were the subject of exclusive clinical option and license agreements signed in the fourth quarter of 2022. </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Expansion of pivotal trial program for zanzalintinib&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In 2023, Exelixis plans to expand the phase 3 development program for zanzalintinib (XL092) with multiple new phase 3 pivotal trial initiations of zanzalintinib in combination with several immuno-oncology (IO) therapies. In 2022, Exelixis initiated STELLAR-303, which evaluates zanzalintinib in combination with atezolizumab versus regorafenib in patients with colorectal cancer (CRC) that is not microsatellite instability-high or mismatch repair-deficient, who have progressed after or are intolerant to the current standard of care, as well as STELLAR-304, which evaluates zanzalintinib in combination with nivolumab versus sunitinib in patients with advanced non-clear cell renal cell carcinoma. As previously stated, Exelixis intends to develop zanzalintinib in novel combination regimens in a broad array of future potential indications, including those where cabozantinib has demonstrated anti-tumor activity. </font></div><div style="padding-left:9pt;padding-right:9pt"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Advancement of the XB002 JEWEL development program&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> In 2023, Exelixis intends to accelerate the development of XB002, its next-generation tissue factor-targeting ADC, both as a monotherapy and in combination with IO and other targeted therapies, across a wide range of tumor types. The dose-escalation stage of JEWEL-101, the first-in-human phase 1 study evaluating XB002 as a single agent and in combination with nivolumab, is ongoing and the company expects to initiate the cohort expansion stage of the study after the recommended dose and&#47;or the maximum-tolerated dose for XB002 have been determined, as well as advance additional combination cohorts in the study to identify sensitive tumor types. Anticipated tumor cohorts across the trial include forms of non-small cell lung, ovarian, cervical, urothelial, squamous cell head and neck, pancreatic, esophageal, prostate, and breast. In October 2022, Exelixis presented promising initial results from the ongoing dose-escalation stage of JEWEL-101, demonstrating that XB002 was well-tolerated across multiple dose levels with a pharmacokinetic analysis supporting the ability of XB002 to remain stable after infusion with low levels of free payload in circulation. The company expects to move into full development by year-end.</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Advancement of the XL102 QUARTZ development program&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> In 2023, Exelixis intends to advance the first-in-human QUARTZ-101 phase 1 trial evaluating XL102, its potent, selective, irreversible and orally bioavailable small molecule CDK7 inhibitor into the cohort expansion and potential combination cohorts. The phase 1 QUARTZ-101 study is evaluating the safety, tolerability, pharmacokinetics, anti-tumor activity and effect on biomarkers of XL102 administered alone and in multiple combination regimens in patients with advanced solid tumors. In December 2022, Exelixis presented initial dose-escalation results from the QUARTZ-101 study, demonstrating that XL102 was well-tolerated at evaluated dose levels with a pharmacokinetic analysis showing rapid absorption of XL102 and an elimination half-life of 5-9 hours. Exelixis expects to evaluate the anti-tumor activity and efficacy of XL102 in additional patients in the single-agent dose-escalation cohorts, in the tumor-specific cohort-expansion stage and in planned combination cohorts. In the cohort-expansion stage of QUARTZ-101, XL102 will be evaluated in patients with certain types of ovarian, breast and prostate cancers.</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="height:20.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.48pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.888%"><tr><td style="width:1.0%"></td><td style="width:55.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">January 8, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page 3 of 6</font></div></td></tr></table><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Advancement of CBX-12 clinical program in collaboration with Cybrexa&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Exelixis expects its partner Cybrexa to continue to advance its phase 1 clinical study program for CBX-12 throughout 2023, including dose-expansion cohorts. CBX-12 is a clinical-stage, first-in-class peptide-drug conjugate that utilizes Cybrexa&#8217;s proprietary alphalex&#8482; technology to enhance delivery of exatecan to tumor cells. It is designed to increase the therapeutic index of topoisomerase I inhibition by delivering exatecan, a highly potent, second-generation topoisomerase I inhibitor, directly to the tumor cells using a target independent approach activated by the acidic microenvironment of solid tumors. Under the terms of the agreement announced in November 2022, Exelixis has the option to acquire CBX-12 upon evaluation of a pre-specified clinical data package that includes certain phase 1 results.</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Planned Investigational New Drug (IND) filing for ADU-1805 program, in collaboration with Sairopa&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> In the first quarter of 2023, Exelixis expects its partner Sairopa to file an IND for ADU-1805, a potential best-in-class monoclonal antibody targeting SIRP&#945; to block the SIRP&#945;&#8211;CD47 checkpoint. Blocking SIRP&#945; has the potential to improve the immune system&#8217;s ability to attack tumors by addressing a significant immune-suppressive component of the tumor microenvironment. ADU-1805 is active against all human alleles of SIRP&#945;, which may allow it to address a broader patient population than other SIRP&#945;-directed therapies, and has been optimized to bind preferentially to SIRP&#945; vs. other SIRP family members, which may enhance its ability to stimulate immune cells. Under the terms of the clinical development and option agreement announced in November 2022, Exelixis has the option to obtain an exclusive, worldwide license to develop and commercialize ADU-1805 and other anti-SIRP&#945; antibodies upon review of data from prespecified phase 1 clinical studies of ADU-1805 to be completed by Sairopa during the option period. </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Advancement of Development Candidates (DCs) XB010 and XB014 toward IND filing&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In 2023, Exelixis plans to advance XB010, the first custom ADC generated through the company&#8217;s biotherapeutics network of collaborations, and XB014, the company&#8217;s first bispecific antibody designated as a DC in August 2022, through preclinical development and IND-enabling studies, toward potential IND filings in early 2024. XB010 targets the oncofetal antigen 5T4, which is overexpressed on a broad array of solid tumors including non-small cell lung cancer, </font><font style="color:#202124;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">head and neck squamous cell carcinomas</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and gastric and breast carcinomas, and utilizes the SMARTag</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> site specific conjugation platform from Catalent, Inc. to produce a homogeneous ADC with a defined drug-antibody ratio coupled to a high affinity antibody Exelixis sourced from Invenra, Inc. (Invenra). XB014 consists of a bispecific antibody, with a PDL1 targeting arm along with a CD47 targeting arm to block a macrophage checkpoint, also developed through Exelixis&#8217; collaboration with Invenra.</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DC designation for XB628&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Today, Exelixis announced it has designated XB628 as its latest DC and plans to advance the program through preclinical development in 2023, toward a potential IND filing in 2024. Comprising a PDL1 targeting arm and an NKG2A targeting arm, XB628 is the company&#8217;s second bispecific antibody program developed through its collaboration with Invenra. </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Discovery Expansion and Anticipated Milestones</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In 2022, Exelixis enhanced the capacity and capabilities of its small molecule discovery efforts and utilized its broad collaboration network to build a differentiated biotherapeutics platform focused on the identification and optimization of next-generation ADCs, bispecific antibodies and other biologics with promising preclinical activity. In 2023, Exelixis is advancing more than 10 discovery programs through internal and collaborative efforts and expects to progress up to five new development candidates into preclinical development, encompassing multiple modalities and mechanisms across small molecules and biotherapeutics. </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Anticipated Cabozantinib Milestones</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;In the ten years since its initial FDA approval, cabozantinib has evolved from an orphan indication to a global oncology franchise that benefits tens of thousands of patients annually,&#8221; said Michael M. Morrissey, Ph.D., President and Chief Executive Officer, Exelixis. &#8220;In 2022, cabozantinib generated approximately $1.4 billion in preliminary U.S. net product revenues, further reinforcing its status as a leading therapy for forms of renal, liver, and thyroid cancer. We&#8217;re committed to maximizing cabozantinib&#8217;s clinical and commercial potential &#8211; including through the ongoing CONTACT clinical trials, which represent the final Exelixis-sponsored pivotal trials of the compound &#8211; as our pipeline buildout proceeds.&#8221;</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="height:20.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.48pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.888%"><tr><td style="width:1.0%"></td><td style="width:55.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">January 8, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page 4 of 6</font></div></td></tr></table><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pivotal trial progress and data readouts anticipated in 2023&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> During the first half of the year, Exelixis expects to report top-line results for the progression-free survival endpoint from CONTACT-03, the phase 3 pivotal trial sponsored by Roche evaluating the combination of cabozantinib and atezolizumab versus cabozantinib monotherapy in a form of renal cell carcinoma (RCC) in patients who progressed during or following treatment with an immune checkpoint inhibitor as the immediate preceding line of therapy. In the second half of the year, the company anticipates completion of enrollment and expects to report top-line results for the progression-free survival endpoint for CONTACT-02, the phase 3 pivotal trial sponsored by Exelixis evaluating the combination of cabozantinib and atezolizumab in patients with metastatic castration-resistant prostate cancer who have been previously treated with one novel hormonal therapy. Also expected in 2023 is the next overall survival analysis from COSMIC-313, the phase 3 pivotal trial evaluating the triplet combination of cabozantinib, nivolumab and ipilimumab versus the combination of nivolumab and ipilimumab in patients with previously untreated advanced intermediate- or poor-risk RCC.</font></div><div style="padding-left:9pt;padding-right:9pt"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cabozantinib Abbreviated New Drug Application (ANDA) Litigation</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; The United States District Court for the District of Delaware has scheduled a second bench trial for Exelixis&#8217; ongoing ANDA lawsuit against MSN Pharmaceuticals, Inc. for October 2023. Exelixis is confident in its cabozantinib patent estate and will vigorously defend the patents at issue.</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Presentation and Webcast</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exelixis President and Chief Executive Officer Michael M. Morrissey, Ph.D., will provide a corporate overview and discuss the company&#8217;s preliminary fourth quarter and full year 2022 financial results, 2023 financial guidance, and key priorities and milestones for 2023 during the company&#8217;s presentation at the J.P. Morgan Healthcare Conference beginning at <br>8&#58;15 p.m. ET &#47; 5&#58;15 p.m. PT on Monday, January 9, 2022.</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To access the webcast link, log onto </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.exelixis.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and proceed to the News &#38; Events &#47; Event Calendar page under the Investors &#38; Media heading. Please connect to the company&#8217;s website at least 15 minutes prior to the presentation to ensure adequate time for any software download that may be required to listen to the webcast. A replay will also be available at the same location for at least 30 days.</font></div><div style="padding-left:9pt;padding-right:9pt"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">About Exelixis</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by bi-coastal centers of discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody drug conjugates and other biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX&#174; (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.exelixis.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, follow </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#64;ExelixisInc</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on Twitter, like </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exelixis, Inc.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on Facebook and follow </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exelixis</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on LinkedIn.&#160;</font></div><div style="padding-left:9pt;padding-right:9pt"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Forward-Looking Statements and Preliminary Financial Results</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release contains forward-looking statements, including, without limitation, statements related to&#58; Exelixis&#8217; expectation that 2023 will be a year of significant growth and execution as it continues to expand and develop its pipeline of promising biotherapeutics and small molecules and pursues potential near-term label-expansion opportunities for CABOMETYX&#59; Exelixis&#8217; 2023 financial guidance&#59; Exelixis&#8217; expectations in 2023 to report data from two pivotal trials of cabozantinib, initiate the next wave of phase 3 studies of zanzalintinib, advance XB002 into full development and add new agents to its portfolio from internal discovery and collaborative efforts&#59; Exelixis&#8217; plans to continue to pursue additional in-licensing and strategic opportunities to enhance the breadth and depth of its pipeline and make an even greater impact on its mission to help cancer patients recover stronger and live longer&#59; Exelixis&#8217; plans to expand the phase 3 development program for zanzalintinib in 2023 with multiple new phase 3 pivotal trial initiations evaluating zanzalintinib in novel combination regimens with several IO therapies across a broad array of future potential indications, including those where cabozantinib has demonstrated anti-tumor activity&#59; Exelixis&#8217; plans in 2023 to accelerate the development of XB002, both as a monotherapy and in combination </font></div><div style="height:20.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.48pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.888%"><tr><td style="width:1.0%"></td><td style="width:55.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">January 8, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page 5 of 6</font></div></td></tr></table><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with IO and other targeted therapies, across a wide range of tumor types, and Exelixis&#8217; expectation that XB002 will move into full development by year-end&#59; Exelixis&#8217; expectation it will initiate the cohort expansion stage of the JEWEL-101 study after the recommended dose and&#47;or the maximum-tolerated dose for XB002 have been determined, as well as advance additional combination cohorts, with anticipated cohorts across the trial to include forms of non-small cell lung, cervical, urothelial, squamous cell head and neck, pancreatic, esophageal, prostate and breast cancers&#59; Exelixis&#8217; plans in 2023 to continue evaluating the anti-tumor activity and efficacy of XL102 in the QUARTZ-101 study, with additional patients in the single-agent dose-escalation cohorts, and to advance the study into the tumor-specific cohort expansion stage, including in patients with certain types of ovarian, breast and prostate cancers, as well as in potential combination cohorts&#59; Exelixis&#8217; expectation that its partner Cybrexa will continue to advance its phase 1 clinical study program for CBX-12 throughout 2023, including dose-expansion cohorts&#59; Exelixis&#8217; expectation that its partner Sairopa will file an IND for ADU-1805 in the first quarter of 2023&#59; the potential for ADU-1805 to be a best-in-class monoclonal antibody targeting SIRP&#945; to block the SIRP&#945;-CD47 checkpoint, which has the potential to improve the immune system&#8217;s ability to attack tumors, and Exelixis&#8217; belief that ADU-1805 may address a broader patient population than other SIRP&#945;-directed therapies&#59; Exelixis&#8217; plans in 2023 to advance XB010 and XB014 through preclinical development and IND-enabling studies toward potential IND filings in early 2024&#59; Exelixis&#8217; plans in 2023 to advance XB628 through preclinical development toward a potential IND filing in 2024&#59; Exelixis&#8217; anticipated discovery expansion activities and milestones in 2023, including plans to advance more than 10 discovery programs through internal and collaborative efforts and expectation to progress up to five new development candidates into preclinical development, encompassing multiple modalities and mechanisms across small molecules and biotherapeutics&#59; Exelixis&#8217; commitment to maximizing cabozantinib&#8217;s clinical and commercial potential &#8211; including through the ongoing CONTACT clinical trials, which represent the final pivotal trials of the compound &#8211; as the pipeline buildout proceeds&#59; Exelixis&#8217; expectation it will report top-line results for the progression-free survival endpoint from CONTACT-03 during the first half of 2023, and to complete enrollment in CONTACT-02 and report top-line results for the progression-free survival endpoint from CONTACT-02 during the second half of 2023, as well as report results from the next overall survival analysis from COSMIC-313 during 2023&#59; Exelixis&#8217; confidence in its cabozantinib patent estate and plans to vigorously defend the patents at issue in a second bench trial for its ongoing lawsuit against MSN Pharmaceuticals, scheduled for October 2023&#59; Exelixis&#8217; scientific pursuit to create transformational treatments that give more patients hope for the future&#59; and other statements that are not historical facts. Any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and are based upon Exelixis&#8217; current plans, assumptions, beliefs, expectations, estimates and projections. Forward-looking statements involve risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in the forward-looking statements as a result of these risks and uncertainties, which include, without limitation&#58; the degree of market acceptance of CABOMETYX and other Exelixis products in the indications for which they are approved and in the territories where they are approved, and Exelixis&#8217; and its partners&#8217; ability to obtain or maintain coverage and reimbursement for these products&#59; the effectiveness of CABOMETYX and other Exelixis products in comparison to competing products&#59; the level of costs associated with Exelixis&#8217; commercialization, research and development, in-licensing or acquisition of product candidates, and other activities&#59; Exelixis&#8217; ability to maintain and scale adequate sales, marketing, market access and product distribution capabilities for its products or to enter into and maintain agreements with third parties to do so&#59; the availability of data at the referenced times&#59; the potential failure of cabozantinib, zanzalintinib and other Exelixis product candidates, both alone and in combination with other therapies, to demonstrate safety and&#47;or efficacy in clinical testing&#59; uncertainties inherent in the drug discovery and product development process&#59; Exelixis&#8217; dependence on its relationships with its collaboration partners, including their pursuit of regulatory approvals for partnered compounds in new indications, their adherence to their obligations under relevant collaboration agreements and the level of their investment in the resources necessary to complete clinical trials or successfully commercialize partnered compounds in the territories where they are approved&#59; complexities and the unpredictability of the regulatory review and approval processes in the U.S. and elsewhere&#59; Exelixis&#8217; continuing compliance with applicable legal and regulatory requirements&#59; unexpected concerns that may arise as a result of the occurrence of adverse safety events or additional data analyses of clinical trials evaluating cabozantinib and other Exelixis products&#59; Exelixis&#8217; dependence on third-party vendors for the development, manufacture and supply of its products and product candidates&#59; Exelixis&#8217; ability to protect its intellectual property rights&#59; market competition, including the potential for competitors to obtain approval for generic versions of Exelixis&#8217; marketed products&#59; changes in economic and business conditions, including as a result of the COVID-19 pandemic and other global events&#59; and other factors discussed under the caption &#8220;Risk Factors&#8221; in </font></div><div style="height:20.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.48pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.888%"><tr><td style="width:1.0%"></td><td style="width:55.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">January 8, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page 6 of 6</font></div></td></tr></table><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exelixis&#8217; Quarterly Report on Form 10-Q submitted to the Securities and Exchange Commission (SEC) on November 1, 2022, and in Exelixis&#8217; future filings with the SEC. All forward-looking statements in this press release are based on information available to Exelixis as of the date of this press release, and Exelixis undertakes no obligation to update or revise any forward-looking statements contained herein, except as required by law.</font></div><div style="margin-bottom:11.25pt;margin-top:11.25pt;padding-left:9pt;padding-right:9pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, this press release includes Exelixis&#8217; preliminary financial results for the quarter and fiscal year ended December 30, 2022. Exelixis is currently in the process of finalizing its full financial results for the quarter and fiscal year ended December 30, 2022, and the preliminary financial results presented in this press release are based only upon preliminary information available to Exelixis as of January 8, 2023. Exelixis&#8217; preliminary financial results should not be viewed as a substitute for full audited financial statements prepared in accordance with U.S. GAAP, and undue reliance should not be placed on Exelixis&#8217; preliminary financial results. Exelixis&#8217; independent registered public accounting firm has not audited or reviewed the preliminary financial results included in this press release or expressed any opinion or other form of assurance on such preliminary financial results. In addition, items or events may be identified or occur after the date of this press release due to the completion of operational and financial closing procedures, final audit adjustments and other developments may arise that would require Exelixis to make material adjustments to the preliminary financial results included in this press release. Therefore, the preliminary financial results included in this press release may differ, perhaps materially, from the financial results that will be reflected in Exelixis&#8217; audited consolidated financial statements for the fiscal year ended December 30, 2022.</font></div><div><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Exelixis, the Exelixis logo and CABOMETYX are registered U.S. trademarks of Exelixis. </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">SMARTag is a registered trademark of Catalent, Inc.</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">alphalex is a trademark of Cybrexa, Inc.</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"># # #</font></div><div style="height:20.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>exel-20230108.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:df7852c8-f4a3-4fc5-8660-dc137a23d35f,g:ba2d0e8a-471d-48f3-a51a-d61364ac11d5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exel="http://www.exelixis.com/20230108" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.exelixis.com/20230108">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exel-20230108_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exel-20230108_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.exelixis.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>exel-20230108_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:df7852c8-f4a3-4fc5-8660-dc137a23d35f,g:ba2d0e8a-471d-48f3-a51a-d61364ac11d5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_1eee44c8-6869-4006-8af1-f3fff44e160f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1026f02b-7248-4610-a694-9e325366461b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_020f6d96-9b71-40ad-8570-610c1ee684e3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_46be40c0-d5e6-4adb-818c-e46f86eefcce_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_331330e6-0360-4b7b-a7e7-9737bfef75f9_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_91da4af0-2bb5-4dd6-9f33-c02f67d3b7c7_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_6e886ee6-4ba5-40d4-bb6e-77bfa7c2603a_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ff023233-1aa6-4fe0-b9c0-75817408681e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a50184e7-6265-4329-beb2-3c63659f790f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f1982464-3a4f-4027-9cf6-a24e9aad64ab_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6d74b632-1def-42ad-9929-5b0122c67e91_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_6d7abfea-648f-43aa-a10b-a4bc52d689a1_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b98afcc0-7d6b-429e-ae5f-d9973c9ea11f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_ed8d27ce-dd7a-454a-af0c-40efdcf56dad_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_68ce7959-ce08-40e9-b9f0-de0b61e6b05d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_809247ec-98d9-439b-ad27-22ce8d3d275b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8cb26c04-39a5-427b-8eda-beeafa9fec2c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_17d4f38a-3b67-47f3-b7a8-973b207a7628_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9a0480ce-98b5-4421-b430-538a485d4553_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_103a8d92-6f6b-4ce9-8c88-87744cd1a941_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_04a4c045-8320-4986-a179-83e5986a25c9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_fe0afc78-8f96-4b3c-9dfc-f79b21ba0a01_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_f4124799-dc84-4ac5-a334-56a1b6d9d70d_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>exel-20230108_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:df7852c8-f4a3-4fc5-8660-dc137a23d35f,g:ba2d0e8a-471d-48f3-a51a-d61364ac11d5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.exelixis.com/role/CoverPage" xlink:type="simple" xlink:href="exel-20230108.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.exelixis.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_75f6e759-ce70-4112-b555-7ee97ddfbbfa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_DocumentType_75f6e759-ce70-4112-b555-7ee97ddfbbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f852fd7b-469a-430f-96ec-afdfea2ff10e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_DocumentPeriodEndDate_f852fd7b-469a-430f-96ec-afdfea2ff10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_88d386b3-2c14-440c-8101-6ed549692061" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_EntityRegistrantName_88d386b3-2c14-440c-8101-6ed549692061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e8a4cb34-04ca-4af6-96ff-75ccf6d7f8fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e8a4cb34-04ca-4af6-96ff-75ccf6d7f8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a67e7345-1145-487f-9f91-b984a9584e5e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_EntityFileNumber_a67e7345-1145-487f-9f91-b984a9584e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_9da46e94-3bac-4ac4-be4c-37149e864cbc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_EntityTaxIdentificationNumber_9da46e94-3bac-4ac4-be4c-37149e864cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7612a7d2-9120-4088-99c3-899d5f9d2bf9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_EntityAddressAddressLine1_7612a7d2-9120-4088-99c3-899d5f9d2bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_dcad422a-40e0-4936-b0d0-e809dff2e64d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_EntityAddressCityOrTown_dcad422a-40e0-4936-b0d0-e809dff2e64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0f17ad63-245d-4d89-b0dc-ccd83f656218" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_EntityAddressStateOrProvince_0f17ad63-245d-4d89-b0dc-ccd83f656218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_948b7ceb-3043-4667-b6c0-f111246bd9f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_EntityAddressPostalZipCode_948b7ceb-3043-4667-b6c0-f111246bd9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_582e874e-55e3-4bfb-860f-b34cd94a48e7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_CityAreaCode_582e874e-55e3-4bfb-860f-b34cd94a48e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e5e39b29-bb31-408d-8c8f-2cd26302e9da" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_LocalPhoneNumber_e5e39b29-bb31-408d-8c8f-2cd26302e9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_ca8dfd33-2816-41e4-96dd-86738d69a86e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_WrittenCommunications_ca8dfd33-2816-41e4-96dd-86738d69a86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_d10619c3-7366-48e4-97aa-f41d17329063" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_SolicitingMaterial_d10619c3-7366-48e4-97aa-f41d17329063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f10b879b-51c5-442a-9963-ad0f58fe5f4b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_PreCommencementTenderOffer_f10b879b-51c5-442a-9963-ad0f58fe5f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_a51241e5-dce9-433a-b679-1ebf35a40f34" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_a51241e5-dce9-433a-b679-1ebf35a40f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f1b61897-5c43-4045-94e3-8aa2df135dda" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_Security12bTitle_f1b61897-5c43-4045-94e3-8aa2df135dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_42487359-de10-4243-ab31-4e4cb1c206c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_TradingSymbol_42487359-de10-4243-ab31-4e4cb1c206c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fbe9fe2f-177b-4615-bfc8-e640c4fff62b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_SecurityExchangeName_fbe9fe2f-177b-4615-bfc8-e640c4fff62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e0f7bb4e-9750-4303-aac4-30c646d116bd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_EntityEmergingGrowthCompany_e0f7bb4e-9750-4303-aac4-30c646d116bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9651176d-6d09-41fa-b81e-676f86b5be33" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_AmendmentFlag_9651176d-6d09-41fa-b81e-676f86b5be33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e8f315b2-647b-461e-aa51-dcdc4092dc09" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c5c37b3-81fa-49f5-a683-7871b2c7b345" xlink:to="loc_dei_EntityCentralIndexKey_e8f315b2-647b-461e-aa51-dcdc4092dc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>exel-20230108_g1.jpg
<TEXT>
begin 644 exel-20230108_g1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M                ]M8  0    #3+4A0("
M                                     !%C<')T   !4    #-D97-C
M   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G
M6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q
M (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $
M#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#
M   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A
M8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M             !)S4D="($E%0S8Q.38V+3(N,0
M                                            6%E:(        /-1
M  $    !%LQ865H@                     %A96B        !OH@  ./4
M  .06%E:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E
M<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%
M0R!H='1P.B\O=W=W+FEE8RYC:
M                          !D97-C         "Y)14,@-C$Y-C8M,BXQ
M($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)
M14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                            9&5S8P         L4F5F97)E;F-E(%9I
M97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E
M9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                             '9I97<      !.D_@ 47RX $,\4  /M
MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                         H\    "<VEG(     !#4E0@8W5R=@
M  0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C
M &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$ Q@#+ -
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MUTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3FY.MT\
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MNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$
M P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0
M 0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E
M\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W
M>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'
MR,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]
M_**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*.(L5GN:5LUQC]^K)NW1+:,5Y15DO)!1117K'@A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY2I[]%'7\:^/:*_%,P\3N(\7*[Q#@NT$HI?-+F^]L_I;*/!'@W 045@U4?\
M-4;FW\F^7[HH^I(O^"PWQL2YDD_M70W63 $9TF+;'CTQSS[D_A78>#?^"X'Q
M'TF51K?ASPGK,(Z^3'-:3'_@6]U_\<KXKHKSZ''W$5*7-'&3^;YE]SNCUL5X
M4<'UX<D\NI)?W8\K^^-G^)^K/P:_X+0_#3Q[<0VOB:QU?P5=28'FS+]MLP3Q
MCS(QO'U,8 [D5]7^$O&6D^/]!@U;0]4T_6-,NAF*ZLIUGBD^C*2/\*_GWKNO
M@7^TCXT_9P\3KJGA'7+K2Y&(,]OG?:W8])8C\K_4C([$'FOT3A[QLQM*:IYO
M352/\T5RR7G;X7Z+E]3\AXN^C/EF(IRK</571GTA-N4'Y<WQQ]6Y^A^\5%?,
MO[#O_!2CPW^U>D.AZK'!X=\<*F38E_\ 1]1P,LULS')(P28S\P'0L 2/IJOZ
M&RC.,'F>&CB\#-3@^JZ/LUNFNS/Y!X@X=S'),;++\TI.G4CT>S71IK1I]&KH
M****],\4**** "BBB@ HHHH **** "BBB@ HHHH **** *FM:Q:>'-'NM0O[
MF&SL;&%[BXN)G"1PQJ"S,Q/   ))K\>/^"A_[;UW^UQ\2_LVFR7%OX)T*1DT
MNV8E?M3]&NI%_O-R%!^ZIQP2V?6O^"L'[?'_  LG5[KX8^$;S/A_39MNM7L+
M_+J4Z'B!2.L4;#)/\3@=E!;X;K^8_%;C[Z[4>39?+]U%^_)?:DNB_NQ?WOR2
MO_;G@+X4?V;1CQ'FT/W\U^[B_L1?VGVG);?RQ\VTGPPM<2K'&K222$*JJ-Q8
MGH /4U^TO_!/K]EQ?V6/V>=/TRZA5?$>L8U'67 &Y9F48ASZ1+A?3=O(^]7P
MK_P2%_95/QC^-C>-=5M_,\/>")%EA#KE;J_/,2_]L_\ 6'T(C[-7ZO5]!X+\
M*^SI2SS$+65XT_3[4OF]%Y)]&?(_22X\]M7APQA)>["TZMNLGK"'_;J?,^EW
M'K$****_?#^40HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K\Y?^"IW_!12XO=1U+X7^!;[RK2#=;>(-3@?YIWZ/:1L.BCI(1R
M3E. &W?1'_!3C]K63]F'X#M;Z3<>3XL\6%['364_/:H!^^N![HK*%/9W0\@&
MOQW=VD<LQ+,QR23R37X/XN<<U,*O[$P,K3DKU)+=)[17FUJ_*RZL_JCZ/OA?
M2QTO]9LTAS4XNU*+6DI)ZS:ZJ+TC_>3?V4-HHHK^:S^T HHHH **** "BBB@
M"?3]1N-'U"&[LYYK6ZMI%EAFA<QR1.IR&5AR"#@@CD5^L'_!,O\ ;_7]I?PT
M/"7BFX1?'6CP;A,V%&M0+QYJCIYJ@C>O?[XXW!?R8K:^'GC_ %;X5^.-+\1Z
M'=O8ZMH]PMU;3+_"RGH1W4C((/!!(.0:^QX+XOQ&08Y5X7=.6DX]UW_Q+=/Y
M;-GYWXE>'N#XLRN6%JI1K1NZ<^L9=G_=EM)?-:I'] 5%<#^S/\>-._:5^"FA
M>,--41+J<&+FWW;C:7"G;+$?]U@<$XRNTX&:[ZO[3PN*I8FC'$4'S0DDT^Z:
MNF?YJX[ U\'B:F$Q,7&I3DXR3W33LU\F%%%%=!RA1110 4444 %%%% !1110
M 4444 %?%?\ P54_;Y_X4YX?N/AWX2O,>*]6@QJ=W"_S:1;N,[01TFD4\=U0
M[NK*:]7_ &_/VUK']D#X6M);-;W?C#6E:+2+)SD(>AN)!U\M/3^)L+ZD?C=X
MD\1W_C#Q!>ZMJEW/?:EJ4[W-U<S,6DGD<EF9CW))-?BOBIQ]]0I/*,!+]]->
M^U]B+Z+^])?<M=VFOZ6\!_"C^UJ\>(<VA_L]-_NXO_EY-=7WA%_*4M-DTZ-:
M7A'PIJ'COQ3I^BZ3:R7FIZM<):6L$8RTLCL%4#\2/I6;7WU_P1;_ &5?[:U^
M^^*FL6V;72R^GZ&KCAYR,33C_<4[ >A+OW6OY_X5X?JYSF=+ 4MI.\GVBMW]
MVW=V74_K3CKBRAPWDE;-J^KBK17\TWI&/WZNVT4WT/M[]EG]G_3_ -F3X':'
MX0L?+DDL(O,OKA!_Q^73\RR^N"W"YY"A1VKT2BBO[BP>%I86A##4%:$$DEV2
M5D?Y@YACZ^-Q-3&8J7-4J2<I-]6W=O[PHHHKH.,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHKE?C?X\_X57\&O%?B4;=V@Z1=7Z
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MTL DV[EMX_O22L/[J(&8^RFOW/\ A9\-=*^#GPYT;POHL/V?2]#M4M8%/WF
MZLQ[LS$L3W+$U\>?\$9?V5/^$)\ 7?Q,U>WVZIXF1K725=>8+)6&Z3D<&5UX
M_P!B-2.'-?<E?U1X1<*_V=EO]HUU^]KV:\H?97_;WQ/RY>Q_"?TA.._[7SG^
MQ\+*]#"MIVVE4VD_^W?A79\W1A1117Z\?SV%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0H YK^AO ?FOC>W[O[_?/Y%^E5R6RQ?:_??=^Z+%%%%?T,?R"%%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG_16OB9_X5-]_P#':/\ AM;XR?\ 16OB9_X5-]_\=KS+YO:CYO:BR"[/3?\
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M5-]_\=KS+YO:CYO:BR"[/3?^&UOC)_T5KXF?^%3??_':/^&UOC)_T5KXF?\
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MXI?$:\L[SQ%I\$\$_B2\DBGC:YC5D93(0RD$@@C!!K]YJ_G4_9>_Y.5^'?\
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M5E9205((()!K]UJ_GG_8I_Y/(^$O_8Y:/_Z70U_0Q6-3<TAL%%%%9EA1110
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M66\G^2Z)+HE9):)!1117<>6%%%% !1110 5^<?\ P5H_;Y_MBYO/A3X-OO\
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M5.S/V:HHHK,L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV_:@^("^-?%5GN\ ^&;@8AE7Y=:NUPPAP>#$G!D['(3G+$?LJB+$BJJA548
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MKF/F]JZ?X*_\EC\)?]AFS_\ 1Z4@/Z/J***Y3H"BBB@ HHHH **** "BBB@
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MYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #YO:OVC_X(E_
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MF]J/F]J #YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J
M#YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]JU? W@;6/B9XOT
M[P_X?TZZU;6=6F6WM+2W3=),Y[#VZDDX  ). ":0'UG_ ,$0O@'-\4_VPHO$
MTT!?2? -H]_(Y'R&YE5H8$_WN9)!_P!<?P/[.UX;_P $^?V.K3]BW]GNQ\.L
MT-UXAU!OM^N7<?W9KIE V(3SY<:@(O3."V 6(KW*N>4KLVBK(****DH****
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M1110 4444 %4M?U^Q\*:'>:GJ5U;V.GV$+3W%S.X2."-1EF8G@  5=K\O_\
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M-[4?-[4 'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4
M'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U
M'S>U'S>U !\WM4NG:C<:3J$-W:3S6MU:R+-#-"Y22)U.596'(8$ @CD$9J+Y
MO:K.AZ)>>)M:M-.T^UFO+^_F2WM[>%"\D\CD*J*!R220 /4T ?K1_P $D/\
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M"OA'2X=)T?3Q\L:?,\SG[TDCGEY&QRQY.!V  ZRBBLS0**** "BBB@ HHHH
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MQ#:V=G$T\\\SA(X8U!+,S'@* "23P *_$/\ X*@_M]W7[9OQ:-CH\\T/P_\
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M[DRV/RZ^;VH^;VH^;VH^;VKI,0^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J
M#YO:CYO:CYO:OT"_X(5?L_>!_CJ?BE_PF7A70O$W]E_V3]C_ +1M$N/LWF?;
M=^S<#C=L3..NT>E*3LKC2N?G[\WM1\WM7] O_#O[X(_]$K\"_P#@HB_PH_X=
M_?!'_HE?@7_P41?X5G[5%^S9_/U\WM1\WM7] O\ P[^^"/\ T2OP+_X*(O\
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M_P#T>E<Q\WM73_!7_DL?A+_L,V?_ */2D!_1]1117*= 4444 %%%% !1110
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M1YG5A[P&OR>^;VK:G'2YE-ZV#YO:CYO:CYO:CYO:M2 ^;VH^;VH^;VH^;VH
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M* "BBB@#^?G_ (*!_P#)[GQ5_P"QFOO_ $:U>0?-[5Z__P % _\ D]SXJ_\
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MH#GCY4\Z3\I)I!_P&OE+YO:NW_:;\7GX@?M'>/M<,GF#5O$5_=J<Y&U[B1E
MZ\ $ >PKB/F]JZH[&#W#YO:CYO:CYO:CYO:F(/F]J/F]J/F]J/F]J #YO:CY
MO:CYO:CYO:@#[)_X(Y?L.V?[3WQANO%7B:U6Z\'^"7CD-M(,QZE>M\T43#^*
M- "[CO\ (I!5FK]G%4(N!P!T'I7S7_P2/^%T/PO_ &#/!02-4NO$,<NMW;C_
M ):O/(2A/TA6%?\ @-?2E<TI79M%604445)04444 %%%% !1110 4444 >7_
M +1_[&_PY_:NT7[+XU\-V>H7,:;+?48AY-_:?[DR_-@'G:<H3U4U^<?[2_\
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ML%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *\G_ &S/V2M!_;*^"5]X3UC;;W8_TC2M1";I--N@#MD'
MJIY5E_B5CT."/6** /YO_C!\(]>^!'Q*U?PGXFLFT_6M%G,%Q$>5/=70_P 2
M,I#*W0J0>]<U\WM7[3_\%8?^">Z?M:?#3_A)_#-JO_"PO"\#&W5!SK%L,LUJ
M?]L'+1G^\2O ?*_BU<6\EI<20S1O#-$Q1T<;61AP01V(KIC*Z,91L-^;VH^;
MVH^;VH^;VJB0^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #YO:OU9_X(P_\
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MK_R6/PE_V&;/_P!'I7,?-[5T_P %?^2Q^$O^PS9_^CTI ?T?4445RG0%%%%
M!1110 4444 ?S.W5S)>W4DTK&269B[L>K,3DDTSYO:G7%O):7$D4BM')&Q1U
M88*D<$&F_-[5UG.'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-
M[4?-[4 ?O[_P3LU^U\2_L-?"VXLS&88_#UM:MY9./,A7R9.YYWQMGWSTZ#VB
MOR]_X(=?MSZ;X6@F^#OBB]CLUO+IKOPU<SOMC:60CS+/)X4LWSH/XF:09W%
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ML%%%%24%%%% !1110 4444 %%%% !1110 5^;_\ P<0_\B9\+?\ K\U'_P!
MMZ_2"OS?_P"#B'_D3/A;_P!?FH_^@6]5'<F6Q^77S>U'S>U'S>U'S>U=)B'S
M>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[5^F?_!NGT^,7_<%_]R%?F9\W
MM7Z9_P#!NGT^,7_<%_\ <A45/A*CN?IE1117.;!1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX9_\#9_\*/\ B(7\9?\ 1._#/_@;/_A1R,.9'ZM45^4O_$0OXR_Z)WX9_P#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M% !1110 4444 %?,O_!8K_E''\1O^X;_ .G.TKZ:KYE_X+%?\HX_B-_W#?\
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M_K,_@,**** "BBB@ HHHH **** "BBB@ HHHH *^9?\ @L5_RCC^(W_<-_\
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M?L1?#W0[J-H;Y]-_M&Y1AATDNI'N2K?[2B4+[;<5E4V+I[GN-%%%8FH4444
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M]M3P=^VG\/?[9\,W#6^H6>U-4TBX8?:M-D.<!AT9&P=LB\, >C!E'K]?SD?
MOXZ>)OV<?B9IWBSPGJ,FFZQIK<'[T=Q&?O12KT>-@,%3[$8(!'[G_L.?MH^'
M_P!M?X/PZ_I?EV6M6.V#6M*+[I-/G(SQW:-\$H_<9!PRL!C.%C:,KGM%%%%9
ME!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 ?S\_\% _^3W/BK_V,U]_Z-:O(/F]
MJ]?_ ."@?_)[GQ5_[&:^_P#1K5Y!\WM75'8YP^;VH^;VH^;VH^;VI@'S>U'S
M>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S
M>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U !\WM1
M\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U>R_L?_ +"WCS]L[Q>E
MGX;L&M=%@D"ZAKEVC+96*\9&[_EI)@\1KR<@G:N6"O8#H_\ @F9^QS<_M??M
M(:?:W5JTGA'P[)'J.O2L/W;Q*V4M\_WIF7;CKM#L/NU^[JJ$7 X Z#TKS?\
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M% !1110 5^;_ /P<0_\ (F?"W_K\U'_T"WK](*_-_P#X.(?^1,^%O_7YJ/\
MZ!;U4=R9;'Y=?-[4?-[4?-[4?-[5TF(?-[4?-[4?-[4?-[4 'S>U'S>U'S>U
M'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U !\W
MM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U !\WM1\WM1\W
MM1\WM0 ?-[4?-[4?-[4?-[4 'S>U7?#'AG4/&GB.QTC2;.?4-3U*=+:UMH5W
M23RN0JJH]22*L^!? 6M?$[Q59Z'X=TN^UK5]0<1V]I9PF660^P'8=23P!R<
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MVH^;VH^;VH /F]JZ?X*_\EC\)?\ 89L__1Z5S'S>U=/\%?\ DL?A+_L,V?\
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M_NRC_B'3_P"JQ?\ EJ?_ '97Z944<\@Y4?F;_P 0Z?\ U6+_ ,M3_P"[*/\
MB'3_ .JQ?^6I_P#=E?IE11SR#E1^9O\ Q#I_]5B_\M3_ .[*/^(=/_JL7_EJ
M?_=E?IE11SR#E1^9O_$.G_U6+_RU/_NRGVG_  ;K1)<+Y_Q>DDB_B6/PN$8_
M0F[./R-?I?11SR#E1\;?!7_@AW\&?AA?0WFN+KGCB[C8,(]4N!%:*P.0?*A"
M[AZAV=3Z5]=>&?"^F^"]!M=*T?3[+2=+L4\NWM+.!8((%Z[510 HZ]!WJ_12
M<F]RK6"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7YY_\
M%G/^"B/_  K[1;KX0^"[[;KFJ0A?$5[ _P UA;N,_95(/$DBGYO[J-CJ_P O
MO?\ P4J_;PLOV*?@ZS6,EO<>./$"/#HEHX#"(CAKJ1?[D>1@'[S$#IN(_#;7
M]?OO%6N7FJ:E=7%]J.HSO<W5S.YDEN)78L[LQY+%B22>I-:4XWU9$I="I\WM
M1\WM1\WM1\WM6YD'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-
M[4?-[4 'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 ?
M1_\ P38_;NOOV*?C&KWLEQ<^"/$#I!K=FN6\H9PMU&O_ #TCR>!]Y<KUVD?N
M5X>U^Q\6:#8ZIIEU;WVFZE EU:W,#AX[B)U#(ZD<%2I!!]#7\TWS>U?H3_P1
MB_X*'_\ "NM;M?A%XROMN@ZI/M\.WDS?+I]R[9-LQ[1RL<K_ '9&QT?*Y5(]
M32,NC/U<HHHK$T"BBB@ HHHH **** "BBB@ HHHH **** "OS?\ ^#B'_D3/
MA;_U^:C_ .@6]?I!7YO_ /!Q#_R)GPM_Z_-1_P#0+>JCN3+8_+KYO:CYO:CY
MO:CYO:NDQ#YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J^F?^"=/_  3I
M_P"&_?\ A,?^*R_X1/\ X1/[%_S"?M_VK[1]H_Z;1;-OD?[6=_;'/S-\WM7Z
M9_\ !NGT^,7_ '!?_<A42=D5'</^(=/_ *K%_P"6I_\ =E'_ !#I_P#58O\
MRU/_ +LK],J*QYY&G*C\S?\ B'3_ .JQ?^6I_P#=E'_$.G_U6+_RU/\ [LK]
M,J*.>0<J/S-_XAT_^JQ?^6I_]V4?\0Z?_58O_+4_^[*_3*BCGD'*C\S?^(=/
M_JL7_EJ?_=E'_$.G_P!5B_\ +4_^[*_3*BCGD'*C\S?^(=/_ *K%_P"6I_\
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MK^ABL*FYK3V"BBBLRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%1116)H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG_Z/2N8^;VKI_@K_ ,EC\)?]AFS_ /1Z4@/Z/J***Y3H"BBB@ HHHH ****
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M_L6+'_T2M>P5X_\ \$_?^3(?A5_V+%C_ .B5KV"N0WCL%%%% PHHHH ****
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MS>U?IG_P;I]/C%_W!?\ W(5%3X2H[GZ94445SFP4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!PO[4'_)M/Q$_[%G4O
M_266OYU/F]J_HK_:@_Y-I^(G_8LZE_Z2RU_.I\WM6U(SJ!\WM1\WM1\WM1\W
MM6IF'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0!Z;^Q3_P GD?"7_L<M'_\
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M_P#H]*YCYO:NG^"O_)8_"7_89L__ $>E(#^CZBBBN4Z HHHH **** "BBB@
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MBFNZQ(S,P55&22> * &WEY#IUI+<7$L<-O"ADDDD8*D:@9))/  '.37X&?\
M!1']IA?VKOVL/$GB>UD:31+=UTS1\_\ /I#E58?]=&+RX/3S<=J^L_\ @K1_
MP52L_&6E:A\+?AGJ0N=/GW6_B#6[=_W=TO&;:W<'YD/(D?HP^494L3^;WS>U
M;4X]3.<N@?-[4?-[4?-[4?-[5J9A\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[
M4 'S>U?KC_P;^^!&T7]F;Q9K\B;7USQ ;=,C[\5O!'@_]]RR#\#^/Y'?-[5^
M^?\ P3:^$S?!C]B'X>:/-'Y5W/I@U.Y4CYA)=,UP0WNHD"_\!K.IL7#<]RHH
MHK U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#^?G_@H'_R>Y\5?^QFOO_1K5Y!\WM7K
M_P#P4#_Y/<^*O_8S7W_HUJ\@^;VKJCL<X?-[4?-[4?-[4?-[4P#YO:CYO:CY
MO:CYO:@ ^;VH^;VH^;VH^;VH _4/]E[_ (+8_"OX)_LZ^"O".J^'_B!<:EX;
MT>WT^ZEM+&S:!Y(T"L4+72L5R.,J#["N\_XB /@W_P!"S\3/_!=8_P#R77Y
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M>S0<[/U__P"(@#X-_P#0L_$S_P %UC_\ET?\1 'P;_Z%GXF?^"ZQ_P#DNOR
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M0>"#51E9W$U<_F@^;VH^;VKZQ_X*I?\ !/N;]C[XH#7/#]O*_P /?$\[&P8
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M!\&_^A9^)G_@NL?_ )+K\@/F]J/F]J/9H.=GZ_\ _$0!\&_^A9^)G_@NL?\
MY+H_XB /@W_T+/Q,_P#!=8__ "77Y ?-[4?-[4>S0<[/U_\ ^(@#X-_]"S\3
M/_!=8_\ R71_Q$ ?!O\ Z%GXF?\ @NL?_DNOR ^;VH^;VH]F@YV?K_\ \1 '
MP;_Z%GXF?^"ZQ_\ DNC_ (B /@W_ -"S\3/_  76/_R77Y ?-[4?-[4>S0<[
M/U__ .(@#X-_]"S\3/\ P76/_P ET?\ $0!\&_\ H6?B9_X+K'_Y+K\@/F]J
M/F]J/9H.=GZ__P#$0!\&_P#H6?B9_P""ZQ_^2Z/^(@#X-_\ 0L_$S_P76/\
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M<G1K9N?*'I*W!<]1]WLQ;QS_ ()+_L#?VM<6?Q6\8V2M:PGS/#EC.F?.<?\
M+XZG^%?^68/4_/QM0G]&J_I#PFX!]E&.>9A'WG_#B^B?VWYO[/9:]5;^-?'[
MQ6^L3GPOE$_<B[5I+[37_+M/LG\?=^[LG<HHHK]\/Y1"BBB@ HHHH **** "
MBBB@ HHHH *X/]I/X#:3^TK\&M:\(:LJK'J46;:XVY:SN%YBF7W5L9 ZJ67H
M37>45SXK"TL31EAZ\>:,DTT^J>C1U8''5\'B(8O#2<:D&I1:W33NG\F?S_\
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MIMW&.6:'?[_>Z^O.9]FQ^T1^Z-%?BG9?\%O?CY:VRI)K'AZY89_>2:-$&/\
MWS@?I27_ /P6[^/EY!MCUGP_:MG.^+1H2WT^;</TH]FQ\Z/VMJ#4M2M]'L);
MJ\N(;6U@4O+-,XCCC4=RQX ^M?A1XL_X*O?M!>,XVCN/B/J5K&V<+86=K9%
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MSI&AEUY%NC9N)1[/(J(#U'DOV:OT:KGJ/6QM%:!1114%!1110 4444 %%%%
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MWM1\WM1\WM0!)9V<VH7<5O;Q23S3N(XXXU+/(Q. H Y))(&!UK]J_P#@E/\
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MFS_]'I7,?-[5U?P(LY-1^.'@VWA7S)KC7;&.-<@;F-P@ R?>D!_1U1117*=
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MWA?P$\VK_P!HXZ/^SP>B?VY+I_A77N_=[V_GOQQ\5ED&$>3Y9/\ VNJM6O\
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M ,EC\)?]AFS_ /1Z5S'S>U=/\%?^2Q^$O^PS9_\ H]*0']'U%%%<IT!1110
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M=I'96D"_\LXT4*O/<\<D\DDD\FMBBBN<V"BBB@ HHHH **** "BBB@ HHHH
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M--+^#7PTT+PIHL9ATOP_916-L&.6*HH7<Q[LV"Q/<DFNAKF;N[G0M$%%%%(
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M1W0'X:?-[4?-[4?-[4?-[5TG.'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#^?G_@H'_R>Y\5?^QFOO_1K5Y!\WM7Z(_M4_P#!
M&CXO?&;]I'QQXLTBY\'KI?B+6;F_M1<:C*DHCDD++N41$!L'IDUP/_#ASXW?
M\_?@7_P:2_\ QFNA21CRL^+/F]J/F]J^T_\ APY\;O\ G[\"_P#@TE_^,T?\
M.'/C=_S]^!?_  :2_P#QFGS(.5GQ9\WM1\WM7VG_ ,.'/C=_S]^!?_!I+_\
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M/C=_S]^!?_!I+_\ &:/^'#GQN_Y^_ O_ (-)?_C-',@Y6?%GS>U'S>U?:?\
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M<K/BSYO:CYO:OM/_ (<.?&[_ )^_ O\ X-)?_C-'_#ASXW?\_?@7_P &DO\
M\9HYD'*SXL^;VH^;VK[3_P"'#GQN_P"?OP+_ .#27_XS1_PX<^-W_/WX%_\
M!I+_ /&:.9!RL^+/F]J/F]J^T_\ APY\;O\ G[\"_P#@TE_^,T?\.'/C=_S]
M^!?_  :2_P#QFCF0<K/BSYO:CYO:OM/_ (<.?&[_ )^_ O\ X-)?_C-'_#AS
MXW?\_?@7_P &DO\ \9HYD'*SXL^;VH^;VK[3_P"'#GQN_P"?OP+_ .#27_XS
M1_PX<^-W_/WX%_\ !I+_ /&:.9!RL^+/F]J/F]J^T_\ APY\;O\ G[\"_P#@
MTE_^,UU'A'_@WR^)%]>JNO>-O!.FVQ(W/8BYO9 /]UXXAG_@5+G0<K/@3YO:
MOLK_ ()J?\$K=8_:CURS\6>-K.\T?X<6["5 X,,_B CD1Q=&$/\ >E'4?*A+
M99/M_P#9G_X(O_"7X#7]KJFM1W?C[7+9@Z2ZLJK91.#PRVR_*?I(9!GGCC'U
MU%$L$:QQJJ(@"JJC 4#H *F53HBHP[D&D:1:^'M)M;"QMH+.QL84M[>W@01Q
M01H JHJCA5    X %6:**Q- HHHH **** "BBB@#A?VH/^3:?B)_V+.I?^DL
MM?SJ?-[5_1_\:?"5UX_^#GBS0;$Q+?:UHUY86YE8K&))8'C7<<' RPR<'BOR
M3_X<.?&[_G[\"_\ @TE_^,UK3DEN9S39\6?-[4?-[5]I_P##ASXW?\_?@7_P
M:2__ !FC_APY\;O^?OP+_P"#27_XS6G,B>5GQ9\WM1\WM7VG_P .'/C=_P _
M?@7_ ,&DO_QFC_APY\;O^?OP+_X-)?\ XS1S(.5GQ9\WM1\WM7VG_P .'/C=
M_P _?@7_ ,&DO_QFC_APY\;O^?OP+_X-)?\ XS1S(.5GQ9\WM1\WM7VG_P .
M'/C=_P _?@7_ ,&DO_QFC_APY\;O^?OP+_X-)?\ XS1S(.5GQ9\WM1\WM7VG
M_P .'/C=_P _?@7_ ,&DO_QFC_APY\;O^?OP+_X-)?\ XS1S(.5GQ9\WM1\W
MM7VG_P .'/C=_P _?@7_ ,&DO_QFC_APY\;O^?OP+_X-)?\ XS1S(.5GQ9\W
MM1\WM7VG_P .'/C=_P _?@7_ ,&DO_QFC_APY\;O^?OP+_X-)?\ XS1S(.5G
MQ9\WM1\WM7VG_P .'/C=_P _?@7_ ,&DO_QFC_APY\;O^?OP+_X-)?\ XS1S
M(.5GQ9\WM1\WM7VG_P .'/C=_P _?@7_ ,&DO_QFC_APY\;O^?OP+_X-)?\
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M,4 \J]@G;<P5B/DC;'!YQ]:<=P/Y_P#YO:CYO:OM/_APY\;O^?OP+_X-)?\
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M:ZH_LWZ-O GL,-/B?%Q]ZI>%*_2*?O2_[>:Y5ULGTD%%%%?@I_58445]>?\
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M-\-O#%IHOA_2['1=)L4V6]G9P+##$/95 ')R2>I)).:UJ**S*"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &3XI\!Z'XXM_)UK1=)UB'&-E[:1W"XY[.".Y_,U
MYKXE_8 ^"?BQV:\^%O@A6<Y9K;2HK5F//),04YY/U_ 5[!11=@?-&L?\$?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX/\ >23TJ27V5WA%_*4M=DFRBBBOVT_F8**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR;U;;U;;[MA1116QSA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !8 4(# 2(  A$! Q$!_\0
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M/QY_:'^)'[0_B2XUCQWK$S6+7'F6.B+.6M;5<MM"I@*S@,09"NYNYQ@#UO\
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MI)IMU>?V9=6FRZ2**5H]ES%&YPDT9W!2OS8SD$#\11_P1D_X*7L=J_LQS?\
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M#/\ V2?3_P#TYZI6_P#\&W@_XR4^(!_ZD=/_ $LAK _X.,?^3Y?#/_9)]/\
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MSN?G[_P<<?\ )GO@[_LI5O\ ^F^^KX)_X(K_ /*3/X9_]=-7_P#3/?5][?\
M!QQ_R9]X._[*5;_^F^^KX)_X(K_\I,_AG_UTU?\ ],]]7V\?@/B/^7A^^UW'
M-+;210R^6[*0LF,[3CK7\M-WI^HZ/>3:5JVG7%G=6LK175I=0-%+#(IPR.C
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MH**** "OQ9_X.+_^3X_#'_9*;#_TYZG7[35^+/\ P<7_ /)\?AC_ +)38?\
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M6UY_PD&H6FRU26658]EM<1H</-(=Q!;YL$X  ]OHH ^5O^')W_!,G_HVD_\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140465917073360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Jan. 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  08,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EXELIXIS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3257395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1851 Harbor Bay Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alameda<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">837-7000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock $.001 Par Value per Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EXEL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000939767<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>exel-20230108_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="exel-20230108.xsd" xlink:type="simple"/>
    <context id="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000939767</identifier>
        </entity>
        <period>
            <startDate>2023-01-08</startDate>
            <endDate>2023-01-08</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV80L2ZyYWc6OTMxNTJhNTZlZGU2NGNhYzgxZjMxODI4MjRmODg0ZDAvdGFibGU6YWQ0NjUzMjdkZjcwNDRiYTk3ODY1MmJjMjU2ODlkZGMvdGFibGVyYW5nZTphZDQ2NTMyN2RmNzA0NGJhOTc4NjUyYmMyNTY4OWRkY18yLTEtMS0xLTEwMDE3MQ_031a00dc-fcfb-4c5f-8801-f66a8df1d44e">0000939767</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV80L2ZyYWc6OTMxNTJhNTZlZGU2NGNhYzgxZjMxODI4MjRmODg0ZDAvdGFibGU6YWQ0NjUzMjdkZjcwNDRiYTk3ODY1MmJjMjU2ODlkZGMvdGFibGVyYW5nZTphZDQ2NTMyN2RmNzA0NGJhOTc4NjUyYmMyNTY4OWRkY181LTEtMS0xLTEwMDE3MQ_82aeaf7e-19ef-4a29-ada6-45b8bc93455c">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6YjAyMjBlNjdjMWIxNDA5Y2E0MzAwNDllZjQ2MjhmZjEvdGFibGVyYW5nZTpiMDIyMGU2N2MxYjE0MDljYTQzMDA0OWVmNDYyOGZmMV8wLTEtMS0xLTEwMDE3MQ_674ad8b8-f357-4f4b-8e33-c3f217bed6c8">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN181NDk3NTU4MTU1NTQ_b89c4d99-3153-406d-bea1-aeaa660bfb84">2023-01-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6MzBhMzA1YTQwOTkwNGU5OTk5MzYyYTI0Yzk2OTA0ZWEvdGFibGVyYW5nZTozMGEzMDVhNDA5OTA0ZTk5OTkzNjJhMjRjOTY5MDRlYV8xLTAtMS0xLTEwMDE3MQ_c3e1d3d4-766a-41b2-be16-c63a3bb9dd32">EXELIXIS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6ZjBkYjRkNzYxM2I2NGUxYmE0OWQ5MGUyYzcxMTJhODAvdGFibGVyYW5nZTpmMGRiNGQ3NjEzYjY0ZTFiYTQ5ZDkwZTJjNzExMmE4MF8wLTAtMS0xLTEwMDE3MQ_e86290bf-d76e-4adb-9323-8c7f4b4f1514">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6ZjBkYjRkNzYxM2I2NGUxYmE0OWQ5MGUyYzcxMTJhODAvdGFibGVyYW5nZTpmMGRiNGQ3NjEzYjY0ZTFiYTQ5ZDkwZTJjNzExMmE4MF8wLTEtMS0xLTEwMDE3MQ_6ea926ae-4414-44c2-8a25-67bd9bc3035d">000-30235</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6ZjBkYjRkNzYxM2I2NGUxYmE0OWQ5MGUyYzcxMTJhODAvdGFibGVyYW5nZTpmMGRiNGQ3NjEzYjY0ZTFiYTQ5ZDkwZTJjNzExMmE4MF8wLTItMS0xLTEwMDE3MQ_754be6af-cf07-4266-9217-72d244f78b9a">04-3257395</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjAz_a7f9835c-85e0-4f5f-96ed-8e1664b0cc7d">1851 Harbor Bay Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjA0_61c4e396-47ce-4722-84c2-f9e2062100d4">Alameda</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjA5_da81524f-a834-4ef7-bef5-0816aa05c2ce">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNTk4_20030266-d5aa-4bec-804f-be4c485f47ad">94502</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjA1_68357d44-61d4-4e72-9d1d-49cb270229bb">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNTk5_10852b01-cd6a-4e61-8946-2c6e2aec3280">837-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjA2_b790cbf2-07e6-4469-9c55-b3df18b73b80">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjAw_60a0dea0-48b4-4345-beaa-d9956e93a62f">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjAx_24bd9b01-9663-4d4f-9a15-e8ced531acaf">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjAy_5816e705-988c-4274-b263-2dcfedcb7561">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6YmE4NjIxOTZhZDc0NDgzYWExNDJjMjk1MzM1MjQwOGEvdGFibGVyYW5nZTpiYTg2MjE5NmFkNzQ0ODNhYTE0MmMyOTUzMzUyNDA4YV8xLTAtMS0xLTEwMDE3MQ_426a4d0a-cb79-475f-ad62-1e5738fbc6ec">Common Stock $.001 Par Value per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6YmE4NjIxOTZhZDc0NDgzYWExNDJjMjk1MzM1MjQwOGEvdGFibGVyYW5nZTpiYTg2MjE5NmFkNzQ0ODNhYTE0MmMyOTUzMzUyNDA4YV8xLTEtMS0xLTEwMDE3MQ_e0899279-50bd-4abe-a7d0-c13b38918f13">EXEL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGFibGU6YmE4NjIxOTZhZDc0NDgzYWExNDJjMjk1MzM1MjQwOGEvdGFibGVyYW5nZTpiYTg2MjE5NmFkNzQ0ODNhYTE0MmMyOTUzMzUyNDA4YV8xLTItMS0xLTEwMDE3MQ_5db133b0-f360-43ac-a638-62536e3bceb0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5MmQ3YWE4Njg1NzRhZWNhMGRmZDAzMDhjMmQ2MjQxL3NlYzo1OTJkN2FhODY4NTc0YWVjYTBkZmQwMzA4YzJkNjI0MV8xL2ZyYWc6NDNhOGRmMmJiODJkNDNhMzg5MTQ2NjM3Y2EyYTJhMzcvdGV4dHJlZ2lvbjo0M2E4ZGYyYmI4MmQ0M2EzODkxNDY2MzdjYTJhMmEzN18xNjA3_8dd8bfd8-829b-480a-aa1e-3c6e8dc362bc">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( .&!*58'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #A@2E6DN'J">X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)O)VE1,'1S43PI""XHWD(RNQML_I",M/OVMG6WB^@#>,S,+]]\
M ].9)$W,^)QCPDP.R]7H^U"D21MV($H2H)@#>EWJ*1&FYBYFKVEZYCTD;3[T
M'J'A_ 8\DK::-,S *JU$ICIKI,FH*>83WIH5GSYSO\"L >S18Z "HA; U#PQ
M'<>^@PM@AA%F7[X+:%?B4OT3NW2 G9)C<6MJ&(9Z:)?<M(. MZ?'EV7=RH5"
M.AB<?A4GZ9APP\Z37]N[^^T#4PUOVHJ+BM]N&R'%M>3-^^SZP^\B[*-U._>/
MC<^"JH-?=Z&^ %!+ P04    " #A@2E6F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M .&!*5;U!3721@0  'T0   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
ME9AK<^(V%(;_BL;=Z;0S";YP3X$90DB7;C;+AG1WIYU^$+8 36S)E>00_GV/
M#-ATUARS7V++^+Q^I'/T2LI@*]6+WC!FR%L2"SUT-L:D-ZZKPPU+J&[(E GX
M92550@TTU=K5J6(TRH.2V T\K^,FE MG-,B?S=5H(#,3<\'FBN@L2:C:W;)8
M;H>.[QP?//'UQM@'[FB0TC5;,/-G.E?0<@N5B"=,:"X%46PU=,;^S6W0L@'Y
M&U\XV^J3>V*[LI3RQ39FT=#Q+!&+66BL!(7+*YNP.+9*P/'O0=0IOFD#3^^/
MZO=YYZ$S2ZK91,9?>60V0Z?GD(BM:!:;)[E]SPX=:EN]4,8Z_TNV^W=;+8>$
MF38R.00#0<+%_DK?#@-Q$M#LGPD(#@%!SKW_4$YY1PT=#93<$F7?!C5[DW<U
MCP8X+FQ6%D;!KQSBS&@B7YDB<TC P#6@9Y^ZX2'V=A\;G(G]@XH&\7I7)/""
MYO_#7< H6(*")<CUFBC+W^.E-@JR]4\5T5ZA5:U@2_A&IS1D0P=J5#/URIS1
MSS_Y'>\WA*]9\#4Q]=&=##,H2$.>=VGE<.'AO>L/"$2K@&A=!C%GBLN(3$5$
M(/.5/+A2GKX\?W4);!=L;51Q*@PW._+$UMRF$" ?:5))5J/S;?HP^S9;7)'9
MXZ2!@'4*L,XE8#,12I5*1:TA7)&%@7$C4I&)S(11.[A&E;2X^-T4(>P6A-U+
M".]YS,ACEBR9J@+!-3S/NVY")ML(3Z_@Z5W"\TS?R"R"<N,K'N;#AM#ABE[K
MNAFTN\T^AM<O\/J7X(VC"*:YOCK>D =XCWP2E5G$%?U>VR?OJ5I"/=S2'5BB
M>MG2'<+J>Z7'>C]$.[$M^,ZSW(I*V\7EQC',JHAB:"?V[_\06C$GYDJ^<A%6
M+PNXYF2,H96K@8^:^7=H<ZD-C<E?/#T[46L4^ZVV%V!LY4K@XUZ>9W ,VZ#S
M*+A I^UA(.5JX.,F_B!#&)/Y1@K,-VI$>LWN=1?< R,JUP ?-^^OBAO#! Q,
MDF3BX!JZD@H76M%8,PRI='\?=^B%C'G(#1=K\A'*6W$:5_+@*K4\I=?[N%'/
M%;L.87@8S*_]AH*)"+8^GU:K,_G#]6K)2M?W<9/^CFRF=09DM8"X;"U@Z?L^
M;M//W, **5?$#WY9_DH6+,R@WG:53+B2K4]8SA9&AB_D7</S?.OYY N-,T92
MZ.QB0Q4&'93^'^"&_:QH9(MOL4N6LK+T:@3LA@@C*>T^P*WY.%YD^A9NJ%BS
MLSNT&J''\>)N_!EC.MGU7^3STX2IM1VEWT'!;*Q_I%149K9&L*[:@M+F ]RE
MQS 'HGP>W,=T78F""]2BE$8?X!Y]&*4)P"AP_!G,QS?R@56/#RX%3N_UF_UN
MIUM%YIX<)NW!_".U:=$D9BM0\QI=<&VU/^ON&T:F^?ER*0V<5O/;#:-@%_8%
M^'TEI3DV[)&U^(_#Z#]02P,$%     @ X8$I5I^@&_"Q @  X@P   T   !X
M;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ
M9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD
M:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N
M0V]H4JPKH\^6E :#7\H4)X],;NB62;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!I
MGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM5X64,\$E#89BW3#GN-5W7AD6#\87
M$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLYS8).IF(M>05TK*B/\.M,DP#HG%%>
M* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5<D].)3"6T@L-5)](1&,80)"L2_C!9B
M7X2]_:VPI!&/QGWL_&[TH'_OC./WEE>B'_2^FO-CT1=X=-8T\O1!BEHK'O;^
MRPF+-9O\R-%8\>2SP:0<O(%;2AZY=>)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/-
M-;=,7I+VH_\W5_DMC)/Q]%P<T:L#.EL)7(0;^A7N5WGF0/:=D$[H43N*LN3Z
MQ3GUX1W;^PO\*KY?7_**==+M9G!#S_(77HI.Y?.J>ZC+N.HL?X;[:)'-M[#/
M)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1' L#P8 \PG>&%Y_J?]K-#]
M! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q
M P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL
M0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^\?Y@IR1-\SR. !9GD*88
M J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ X8$I5I>*NQS
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M/UY_ 5!+ 0(4 Q0    ( .&!*58'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ X8$I5I+AZ@GN
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ X8$I5IE<G",0!@  G"<  !,              ( !S $  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " #A@2E6]04UTD8$  !]$   &
M            @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ X8$I5I^@&_"Q @  X@P   T              ( !B0P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " #A@2E6EXJ[',     3 @  "P
M    @ %E#P  7W)E;',O+G)E;'-02P$"% ,4    " #A@2E6&445]3<!   G
M @  #P              @ %.$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ X8$I5B0>FZ*M    ^ $  !H              ( !LA$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ X8$I5F60>9(9 0  SP,
M !,              ( !EQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  X1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="exel-20230108.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exelixis.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="exel-20230108.htm">exel-20230108.htm</File>
    <File>a230108corporatepriorities.htm</File>
    <File>exel-20230108.xsd</File>
    <File>exel-20230108_lab.xml</File>
    <File>exel-20230108_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>exel-20230108_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "exel-20230108.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "exel-20230108.htm"
     ]
    },
    "labelLink": {
     "local": [
      "exel-20230108_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "exel-20230108_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "exel-20230108.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "exel",
   "nsuri": "http://www.exelixis.com/20230108",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exel-20230108.htm",
      "contextRef": "i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.exelixis.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exel-20230108.htm",
      "contextRef": "i32b63597a4d6465098b1f3263d3d5d43_D20230108-20230108",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000939767-23-000003-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000939767-23-000003-xbrl.zip
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M[O!3>] =6-ZQ,B!? 03XV9]@;OU9QG(H4+R5:&.,02R,E'G&V1[T !TD,"2
M;6R3K:-/1R_8SM$<$XIU !(:A_]&ND"I@LI&P]]G;;3*08JCG1/+ H %.Q6$
M!DA24%*:A-/E!&P?-#NMOD+13<$=>$Z2E"K >L]0I5F5Q%(0B U.6F8A6[89
M3KI&R086(/Q986K[+IA*X*PC'TTYF86-2'(JAZ*\$4:S H0"@$2\X5\!//!9
MP+_MB$/2CQ<Z+7.0X[ '.-?:68-F#HF4[:2N!6@3T Q1#68X1'"C$U+V$DS5
M5 (6LTS.$#>CLB@S7^?K)+3#WOTYSL4D!3J_G* PKGDX&/T+50P_)U.9=6N[
M*&,\(A3E<-;K"%P_?3%Z6)^<BM3*GM'?3WX[>=<DB6JW=]VG#!4-[G5%>S(
MNE69]0Y]P.T4V6:;K0"7!ARN$=!%FK4+F8U5@<0%5E=+#%-D%[!EP%9+C%W$
M/EX3#[[]2%_1[P2OI,)*4@*[H^#!U2XU3M/%V#-AG0BSF$U1FF(H.@2Z;JL<
M3 A>G0?7PB_I5-J];J_%-H/.<KPKI3T!SD^,W.^1%SRST@/WPD=*^T ;#^,*
M8^OH7BM,6B@SP7-+K>_I6=ANZ!]@O^:9!^D$??MJEIX#GRPF HXE)OX;7<8X
M1CLUI'WC:ZC:Q<PWC.65CLNXS4*UL+]"?<C;(F%,<?Y0X2@_()RP)EFMJ>?Y
MU/Z.&=S<VF$,'^X)+6?@2-"#=.<E%M/Y!^5[:?R%7<D<,ZYF52_/3\;\16[3
M:QSI(6D;E5BKGUY(^'72@L^R"[0?6Z+,D)@BC7_/P32,00CS(WC))9U(HH+S
M%@CXA.[1U$$+G*<4*&&L\"%@6I+8;%1C2" O2&-_!'(?JFRY)U1Y!'RXWN1)
MBM=,E".,5<BU$L<LN4$=\_%=FI/R#MC@S]DT=. 1<K158$CJ62R#%!P;8-<
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M9W<>5B63S=)FFV4>M88:6_;']+XVAFPPL&B^;L\;(X8T;*:^D;S?)AYG+*P
ML%>'V+)GI8'7AFHNSE7W4%56H/HA*X)"\E;MLW9FQC-JVSBQ^4,HBDVYP:;<
M8%-N\ V6&PR^UW*#)VP"FQ2%RRS8L#!Y[UZFI)89>3B;>,$T( M69D4"UI/-
MVV#]G9?YMJ8R_=18E6Z_;%/ZP7"#D6*2I>5X@K<2L15>A0?94G!JV^EU\R36
M9K@7M$FIMRH;/8@DN*!3!>91J.93<F2=E058L'\";SILVXQCEDXSK0H4,C*"
MK43J"K[<WN\?B$(%DX3#Z%ZZWERV,.,T$KP!T_%HF'-8 8P_-$<H@!TJDS:B
MJ OZ_#D;6U[2#N.EZHH\IW2:ZCR-X2OXV5MK^",ZP TUKZ7$G'DK)A8Q" Y>
M1.5PP,;#6LBL>=4T RM68_0]FMG0M[<#47(%@XF,$9 V/TDW\DF<0X1V(AE.
MIJ)%!CJ$'5',7B47.DL3RQ-U^_Q7S)_S.Y6)LM#S-M_F7[.1B _@GS>9\A@Y
MIM#&U.P4 /BCU)E+$I93K'TVC@T;SA(= &MQHC'IDIJ83)[*X!RE+F<@;+FU
MM0(MH1L'81,0:):&I\9.?YM<*'C_6!I/ =7B,?+FUML/QR^ >W'J!8F'^41N
M:XFH-#GA!PT?N.# 7/;7CRDT"5*;W<8HDZ80@  TU+:/_%QY\4/E"S<,:0<1
MX='6'H@J_OWY[:?3'Y^_VMXYH M=HC0X)T"KS\W=.D?'VWLBF*C@'*1"4G3$
M+_C;N24L7U6PH/R*\5X*%E^49 2+? 8>?.Q$J0W?(1\6A400B-U1.@"5TCUQ
M)%/\0A)>JHV10/K!!4?HTL0+)[%<FI<JG8IL4#N8ZHJQQ!2AP# *1V[@;RIB
MYZW:HDW:Q7BC#]ZO@7?:D%HC,&V6JZJ6 EQ,31@1A4-B\@;5BFT6IG,I!/ .
M$9D4\$8I%0.QD38 !Q8=1T5WBB&*60I[AW !8K)ZB6 Z%C$)PMR'W^HE)#;O
M"(#S8H38G9;13$M$;U-Q!X>I3%G$EXKF=$@R%,,5MO8"=I%F44CY%5MRX64F
MN;+$EC\"YJH#KS(W%+;PT&:8 TOL2/IC,A3D#NRR*E^<<I4(*X!&Z\64);KW
M\2U)MNF ])WEY[#,;,S,;'8*PB4--\4@JQG+QQZ]'<&YZI"2Z%O'1_D++F<R
M=4Q8T52DEYB2)\%)ZN-15HEX9:M8C%5IC  0#O1W>'QD9CVQO""CN+$>;OZR
MK$05P#+G5)-0J[EJ54AJ-:[$  RUB[4Y+<)&*H<J4?(!<,"GA^48@#5L;4%<
M4@1&[X8S::L$"P&!&PP/M>R!59JD.CJN'9191+U#VQUSV*S4C/1(@G2D"J/S
M &5BY\P57&"R$R\]NYJ:PHZTH3K!-SL];Z,AI6>B=ZWKB G@[/6WOP(QU1*$
M<\E#5]V1/P29,V&-95YD1#0V+^F!Q3]Q'A;9'>\//YW)\5H!WNOT;IR!T+]N
M!L+^M4,0^**X![$J<ZQL\H+@[+F2*H$=8!Z:]=81:+"(W#RZHQ +T&GD/][?
M-TGC%&4*D@W*%Y-<P%HHM,71)VX[EB>A 2\JIQ&;(^Q'"CD:85)D5@D')]SR
MM,Q0YQ,@:-DGF;1W)9I_ON@8*0T[R'5>Y.QO-<B<E@7O]/A=SS-C)>P4LT%C
M^SV9J_7OG7TKP?H!BY"RYYY)"]08Y<Z(\.3K_$7##?Z%V<C&L6O6W$!65ED@
MRKBJ8[>__W!*^"REMDQ'I?[MG*:PS"DW I6OK\P%&L8@Q&!'E,&9U]SD_9CX
MU4W*3UM#P.@ZV:CMS,] S1V!9LZT<86:&("3>A_^\=?^8?VKEMF#SAM5/,=^
M&G6\W<LB5R RKN&$QVG$/IKFCV-72']2R\7[Y4;?2"_(8N&P<3Q-G9F<RL#F
MC/$?Y(D:/PJ);*ZTH:$%H3(B^')=-N7JQ&D-8-0"I8Z0VT(]LEXTN69S)G.E
M0E,PO]E,I!@&5XR94E7GZH*'[F*%\]6'H%?!V%GD+VVNK&6/U'8 FA1R59KE
M"Y"JL/6&/D0P7!5'', VKI!F.QXJ/K:]'4M[VLP]OB[[[UIXRBD'I2ZX(-V7
M;4'ED%'QR=(N$)60-.((CZOAB$$\&RK E\<*6_AU'KNJNZ:+?^<.<"."5N\_
M._+KJK\1N5.UZW+,*J&"/&S(L4$O6\?SYOB0<Q,76$RY4&.N+M+HPEJP&,'+
MILA65;DZ&\+C*!UB-Y#KV;5=MYP4&((X&.%;"Y68X!F8W!(KR+"WQ5:/@"%2
M8E#O'EIUG6"N[;B*+Q!*KG2,/10S\4.OLPTLQK-CN*_+C?#XM?.Y@Q)VX2:Q
MEAAAOY/""1DTV(-$$TGU0A;@<5#@( (GUH3"J/*:;BNW1;34KM"B]M*L9:J3
M9UFJ0^-W=\1OMLDV(],FUD7!S@D5%>L_-?GHU1:=W5,)U5K T#/#[(7S?C="
M%72QE;%''S^<'1Z=5>MQ:[.--V3*E(Z9@ X*6WL8[7P*/D^*U6R+?='65@/+
M-'2@ ,9J[;VDS3 Q"K@/E KS!^R^W103;8J)-L5$WV QT?:FF.@Q&3Q+TN>+
M_;&4DDQ,PSM.B@!%D9/W82T_$X1XN,SX<94&XU0#%B);[8<66T-ZO!HM C*A
M36K0U5Z;AB*[?= E;6KMR,OL0E]@X7T24KS/A$99=[>Q<]7OSJUWU59:>C@#
MI@HF:K[LW:\MGAMIPH&9AA[7VH_\UC-JER3?TQI <Q%]L?7IZ.A%O>QXDOK-
MJB:[2)84YJD)3NP=(O>,HZ2)R_"Z(*C7-& 2L? 3%5+7%_IPBHP@.\;&P.N*
MJ$T@:?$$_8:RBOIRFQ@U2%-)!K"ZQ-":3QNKR>QA]U<^[(KVON"\%\K#8U5(
MM( Q:B^Y'0 @1SL>NX>+^<KPJAV9"@*\1ETZ4CLJ ;LAN EW K1#)1_NA XQ
MMLT8K;C>!@1IRDY*?>!1A3K73V 8Y?/[MT?M0>]:1IG#$GR(YWL=MEI>4S/5
MZT]UA*V %9LTH'OI(PN8]G!5)A9;KOF#@A^&OMO(+-,TQ0G3^;D !EO#[,^G
M'[NOA08.AT/$)R'1564=3J>1]82W#C\<'[X0[[0MWWH(G<)I!>Q;^C6AD9"?
M"Y(VQYJ2D84XPBD<3GBXCZFH()*7V-^/CG\.<C$L,=,E78Q<@4]O:!V?G\\-
M69<0T2!@J;S4A:LM>O_Y _CLU+1#(2KR$2D3ADMYO9J#3BVH!V\>L8,/Y$UQ
M=_],4)+B78XL,) ?J#_E0H_3C D_5"-EAT_0CW-!<Q+R\D&GG3Z!&-DI.^Y5
MI/<W-42!_40X^H;A3"L%CJZ//1&I8>0,2[$D4&HV3:D]'[4)%5"1^:GSH,R;
MDT]^'&EN.@X^2HVU,S>*M9H3:TP ]LB\S\>E#E&X<ZSH7&'(6Z>9%TQVX4UB
M.WK<J\5J@,\C 8[A_+US2L@8@PGU-R6C8H*#/D"L))10"%!/@\.?4/JM$,@-
MG.OL[8AI)P;N/A/4_2YV:A^?GF&2X3T(&DQ.6J_S58N'!#U*5GUX<C[CL1"&
MO"Z90=%$/6^)* 43&/,/-ZBAT6CM@%TG5BXO+SO*AF.!X![$\3(=B!@SM'7\
MH-)S(,P!:,^3"](33*7T#W&$-22AQ-+6L1*E*P?E<FVLD^)'WZ,]1:,+@%*
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MCX3(TDZ\U:VK]7<S^"5M];X*)F&C?]UUZ%[M/9!Y52AO2A'6#%[?!V^N:\#
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M8#R:8Y\CE6B9&1#Z?PKP$ IZP).2$Z,]V4!'QTT$LIR'C-N:TI]9R4\#WW.
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M'V;:D3O('XB4E'13GL[;AW64U@G[2G:;%@Q7;??]8AV=8+?CB]%O4$L#!!0
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M'6*^-7HXKUA8IVL2%F<>*Q\0I7_[\(MCJ*GDG1PMGS4B@W7?1HNMV'BL+):
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MTD(8U6YV^D*C9-G[;ZR;UKK=,NMZ9T=;?AS)<I(>OWTW0'$P4NCYUZ^L%P"
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MZVVO!J'%S<TG<(MAGK"E$*I"/[(7O7,#QC[B>7K^&+(WQ5*E?4"V0R LH65
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M/!0.<4@;G"O4X/P4ZL8UH3W>KSTF\U0QO&%EHW,P@^1507N%N0<]X+UGU2#
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M^[R:O+SJ.^?R)O7]C?0_@/3%A'.?13GA 88@+G/A[VF6N;D)R"Q N%N7X$8
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MS])YQ32&4NPOR@0_Z^OIRBBR"/\*&QP@);RGY=!WVR%$RE9N][[RC34N5F>
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MH^/H/Y(3I9]AWF_3M_V<>;NR9S^%A?":7>75GE5;1W]9'G2@[_?/]&9KZVP
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MD##@MPAG':<L.+/:?9GKNJGK)=TJW9RL_@/_3M?A2C0Y$-8,6[M*E0&<^"+
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M1Z+V% H.N7@<YSRLWJ";319M'+Z'<2CF/;Q/_NL-F^+WI<(A%,4@NGNML_T
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MO][EEW[/\_F(?$C^(PU.?;-7?T0-_LR%A$ (UR";*IU!&)(,##G;CSX&K,P
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M_RH?__HI)9H6?4S+_;HD1[@T.WO8.L&B<7D*-S0XV-"-ELICNWKWYHRET%/
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M&W0X)TH0_ 6<>)$6VTQ5@";/, 7"-D1)>Z3.[C3,(M _]2>L4W3MC_Z7:,O
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MX+_J_K:;*4?L=G5A]5)0M+[$/%*,*4S!$*7=U7JE'VG")(?QY&9^>N")I\I
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M3GD.D/U&.S2KOOS0JS0CHJ]&R:?"TH".IB86)!+Y[(#+-2Y 3EAJT!T X#B
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M,!,/G1Z*\+)PVK)TF&:X>:#.]R8A=-W1*+P]H3JI21OJ.8^?R_#2H&KK[-_
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M 4GP1M]>JK7>QRBXV"MC:+[$#X6;BU',Y83@HL 6\L#DRMI :&PY,8G/'U_
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M$!QP<#<@'#JA:V!X)X2^2);K_W1U(?T91% 100F@2>3K+,\$B,,( AT=N*X
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MG 3>Y'(G->\8&TRZ36YLZ[1Q3,^B_DN^+-G\W^EUE7*(B'!" @1\(;4\$1.
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M=WEN'NR_T*?.8D@1CB0'-!94WT!2?>^H\R1 B,M8!/HP;-W9W38\-ED^O,W
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MAHD%'0CKOF>I@8W^NY:>&OXU^Y8:W&O<N=0TOGO'^>']B;]KRS,E(5,\TB6
MHN;QP8 #*A0'*J()\A,&&6Q=$5AG&%L0>&C#KE!Z&J9G<+JWH^M$MN]+=Z9G
MJ 9U6V8Z]:JMWO=J6M<M#MZ]MCID:V/;!_9^<<#V<^P*^PA'E +!8PPPXR%@
M08!!2)B?$$%%!%NO\39/,S9)[SSP_BQO">CU?H#_DS<#'/V5 $=Z&< 87@/@
M]@( ET?_MW^),WUT\F+S2;IZ]_C)B_\!4$L#!!0    ( .&!*58P" 1PHP8
M .@P   5    97AE;"TR,#(S,#$P.%]P<F4N>&ULU9I;;]O&$L??_2E4G=>S
MUMXO1NS"QTT*HVYC)"Y2G!=A+[,R$8HTEG0L?_LN:;N)+T$)48"9%TDDEYS9
M__RT.SO+-S]OUN7L"Z2FJ*O#.=G'\QE4O@Y%M3J<_WGQ#NGYST=[>V]^0NBO
M_WTXF_U2^^LU5.WL)(%M(<QNBO9R]BE \WD64[V>?:K3Y^*+1>BHO^FDOKI-
MQ>JRG5%,V=.KZ2!$I07U&D5N&>+1"Z2EQ"AXPI2E+# 1_[LZ<)8&#-HBKDA
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M<RYH=&U02P$"% ,4    " #A@2E6]+S@&T46  ! A@  $0
M@ &I*   97AE;"TR,#(S,#$P."YH=&U02P$"% ,4    " #A@2E6;R(N86P"
M  ![!P  $0              @ $=/P  97AE;"TR,#(S,#$P."YX<V102P$"
M% ,4    " #A@2E68=$JD5D1 0#"Q@$ %               @ &X00  97AE
M;"TR,#(S,#$P.%]G,2YJ<&=02P$"% ,4    " #A@2E63H??%W *  !)7@
M%0              @ %#4P$ 97AE;"TR,#(S,#$P.%]L86(N>&UL4$L! A0#
M%     @ X8$I5C (!'"C!@  Z#   !4              ( !YET! &5X96PM
F,C R,S Q,#A?<')E+GAM;%!+!08     !@ & )(!  "\9 $    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
